Hemangiopericytoma: histopathological pattern or clinicopathologic entity?
The tumor designated by Stout and Murray as "hemangiopericytoma" (HPC) more than 50 years ago continues to represent a source of uncertainty and disagreement among pathologists. In particular, questions exist regarding the synonymity of a hemangiopericytomatous growth pattern--defined by a monomorphic population of compact polygonal or bluntly fusiform cells and a branching stromal vascular pattern with a "staghorn" configuration--and the presence of a reproducible biological entity. It has been shown repeatedly that these same histologic features may be observed at least focally in a diversity of neoplasms, including "true" hemangiopericytomas, synovial sarcomas, mesenchymal chondrosarcomas, infantile fibrosarcomas, malignant fibrous histiocytomas, malignant peripheral nerve sheath tumors, leiomyosarcomas, endometrial stromal sarcomas, solitary fibrous tumors, myofibromas, malignant mesotheliomas, thymomas, sarcomatoid carcinomas, malignant melanomas, and "phosphaturic mesenchymal tumors." Despite their potential sharing of the microscopic attributes in question, such neoplasms have individualistic clinical features and can also be distinguished from one another by specialized pathologic analyses. HPC is "defined" in that context by reactivity for vimentin, with or without CD34 and CD57, but it lacks other immunodeterminants of epithelial, neural, and myogenous differentiation. Paradoxically, this phenotype is indeed associated with the presence of myogenous-type cytoplasmic filaments in ultrastructural evaluations of HPC. Other lesions that may resemble "true" HPC--but which possess dissimilar subcellular and clinical characteristics--include solitary fibrous tumors, hemangiopericytomalike tumors of the sinonasal tract, and "infantile (congenital) hemangiopericytomas." Such observations suggest that the hemangiopericytoma is both a pathologic entity and a morphological pattern, and they emphasize the utility of adjuvant pathologic studies in this diagnostic context.
Nappi
O
O
Department of Pathology, Benevento General Hospital, Italy.
Ritter
J H
JH
Pettinato
G
G
Wick
M R
MR
D000199:Actins / Q000032:analysis; D001859:Bone Neoplasms / Q000473:pathology; D018959:CD57 Antigens / Q000032:analysis; D003937:Diagnosis, Differential; D006393:Hemangiopericytoma / Q000175:diagnosis / Q000473:pathology*; D006801:Humans; D007633:Keratins / Q000032:analysis; D008579:Meningioma / Q000473:pathology; D018224:Myofibromatosis / Q000473:pathology; D009303:Nasopharyngeal Neoplasms / Q000473:pathology; D012155:Reticulin / Q000032:analysis; D013584:Sarcoma, Synovial / Q000737:chemistry / Q000473:pathology; D012983:Soft Tissue Neoplasms / Q000175:diagnosis / Q000473:pathology*; D017154:Stromal Cells / Q000473:pathology
D000199:Actins; D018959:CD57 Antigens; D012155:Reticulin; D007633:Keratins